← All organizations

Tuscaloosa Research & Education Advancement Corporation (TREAC)

Academic/Hospital

Also known as: Lori Davis, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 1, 2012

Timeline

1990s

Jan 1, 1991
Tuscaloosa Research & Education Advancement Corporation (TREAC)— Founded

Drugs by trial phase (11 distinct, 9 trials)

Phase 4 (9 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

quetiapine

Phase 2 (1 own, 0 via acquisition)

nepicastat

Indications

Studied for

Recent trials (16)

NCT01587118Overall official - principal investigatorPhase 4Jun 1, 2012
NCT01587118Sponsor investigatorPhase 4Jun 1, 2012
NCT01587118Lead sponsorPhase 4Jun 1, 2012
NCT00659230Lead sponsorPhase 2Jul 1, 2009
NCT00659230Reponsible party - principal investigatorPhase 2Jul 1, 2009
NCT00315900Lead sponsorPhase 3May 1, 2006
NCT00315900Reponsible party - principal investigatorPhase 3May 1, 2006
NCT00203567Lead sponsorPhase 4Aug 1, 2005
NCT00203476Lead sponsorPhase 4May 1, 2005
NCT00203476Reponsible party - principal investigatorPhase 4May 1, 2005
NCT00203528Lead sponsorPhase 4Jan 1, 2004
NCT00203450Lead sponsorPhase 4May 1, 2003
NCT00203450Reponsible party - principal investigatorPhase 4May 1, 2003
NCT00203385Lead sponsorPhase 4May 1, 2003
NCT00203385Reponsible party - principal investigatorPhase 4May 1, 2003

Details

Founded: Tuscaloosa, US Jan 1, 1991
Last known activity: Jun 1, 2012